Oncoplastic Techniques and Mastectomy in Breast Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 20 April 2025 | Viewed by 1991
Special Issue Editor
Special Issue Information
Dear Colleagues,
Breast cancer is the leading oncological diagnosis in women worldwide, accounting for more than 287,000 cases in 2022. Among multidisciplinary treatments, surgery maintains its leading role in terms of locoregional control, locoregional staging, and risk reduction strategies. Oncoplastic breast surgery has gained popularity across the world. There has been a paradigm shift towards the de-escalation of various aspects of breast cancer surgery without compromising the oncological outcome. The wider use of various mammoplasty techniques has helped to expand the scope of breast conservation surgery. Newer localisation techniques for clinically non-palpable cancers have significantly helped surgeons to use theatre time more efficiently with a better patient experience. Likewise, the availability of better implants and acellular dermal matrices and other meshes has been instrumental in widening the reconstructive options available to our patients. The future of breast surgery is exciting with ongoing innovations in various fields such as resection margin assessment methods and with the wider application of artificial intelligence in various aspects of breast cancer management.
The present Special Issue will provide an overview of the latest evidence in the field of breast cancer surgery focusing on BCS, oncoplastic surgery, prosthetic breast reconstruction, and reconstructive strategies. Therefore, we welcome the submission of review articles and original research papers.
Dr. Giovanni Papa
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- breast reconstruction
- mammoplasty
- breast implants
- acellular dermal matrix
- direct-to-implant reconstruction
- two-stage breast reconstruction
- breast-conserving surgery